Barts & The London NHS Trust
251
42
50
153
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
10.0%
25 terminated/withdrawn out of 251 trials
86.0%
-0.6% vs industry average
10%
24 trials in Phase 3/4
7%
11 of 153 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (251)
Longitudinal Population-based Observational Study of COVID-19 in the UK Population
Role: collaborator
Atrial Functional Mitral Regurgitation and Tricuspid Regurgitation
Role: lead
Use of TrachPhone in Tracheostomized Patients
Role: collaborator
The Growing Well Study
Role: collaborator
Convergent Ablation Plus Left Atrial Appendage Isolation for the Treatment of Persistent Atrial Fibrillation
Role: lead
Clinical Evaluation of an AI Risk Prediction System (AI-TRiPS)
Role: collaborator
Investigating Pathological Mechanisms in Non-alcoholic Fatty Liver Disease
Role: collaborator
RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome
Role: collaborator
Mechanism of Chronic Pain in Patients With IBD
Role: collaborator
Multifidus PET Scan Study
Role: lead
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA
Role: lead
Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma
Role: collaborator
AIC Genotyping Study
Role: lead
Personalised Ablation Strategies in AF
Role: lead
Development of an AF Specific Quality of Life Questionnaire: AF-PROMS
Role: lead
EEG Monitoring for Refractory Status Epilepticus
Role: lead
Diet-drive Gut Microbiome and Outcome in Patients With Early-stage Triple-negative Breast Cancer Undergoing Neoadjuvant Chemotherapy and Immunotherapy.
Role: lead
Investigating Implant Surface Effect on Osseointegration: NGA vs. ModSLA
Role: lead
A Novel Wearable Digital Biomarker for Detecting Changes in Multiple Sclerosis (MS) Condition
Role: collaborator
Feasibility of a Tailored Online Self-compassion Intervention
Role: collaborator